{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T03:10:36Z","timestamp":1649041836529},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s10147-007-0741-3","type":"journal-article","created":{"date-parts":[[2008,8,13]],"date-time":"2008-08-13T20:24:41Z","timestamp":1218659081000},"page":"361-364","source":"Crossref","is-referenced-by-count":0,"title":["Long-term survival after multimodal therapy in a patient demonstrating intrahepatic cholangiocarcinoma with hilar invasion and intrahepatic metastases"],"prefix":"10.1007","volume":"13","author":[{"given":"Soichiro","family":"Morinaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Sugano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroo","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Shiozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Akaike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Sugimasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,15]]},"reference":[{"key":"741_CR1","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(05)67530-7","volume":"366","author":"S.A. Khan","year":"2005","unstructured":"Khan SA, Thomas HC, Davidson BR, et al. (2005) Cholangiocarcinoma. Lancet 366:1303\u20131314","journal-title":"Lancet"},{"key":"741_CR2","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2005.03.040","volume":"128","author":"K.N. Lazaridis","year":"2005","unstructured":"Lazaridis KN, Gores GJ (2005) Cholangiocarcinoma. Gastroenterology 128:1655\u20131667","journal-title":"Gastroenterology"},{"key":"741_CR3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000077991","volume":"66","author":"J.O. Matthew","year":"2004","unstructured":"Matthew JO, Rodrigo E (2004) A review and update on cholangiocarcinoma. Oncology 66:167\u2013179","journal-title":"Oncology"},{"key":"741_CR4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0959-8049(97)10166-6","volume":"34","author":"M. Hejna","year":"1998","unstructured":"Hejna M, Pruckmayer M, Raderer M (1998) The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. Eur J Cancer 34:977\u2013986","journal-title":"Eur J Cancer"},{"key":"741_CR5","first-page":"326","volume":"49","author":"K. Hirohashi","year":"2002","unstructured":"Hirohashi K, Uenishi T, Kubo S, et al. (2002) Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes. Hepatogastroenterology 49:326\u2013329","journal-title":"Hepatogastroenterology"},{"key":"741_CR6","unstructured":"Japanese translation of common terminology criteria for adverse events v3.0 (CTCAE) by JCOG\/JSCO, October 27, 2004 (2004) Int J Clin Oncol 9(Suppl)III:1\u201363"},{"key":"741_CR7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s10147-003-0343-7","volume":"8","author":"Committee on Classification of Regional Lymph Nodes of Japan Society of Clinical Oncology","year":"2003","unstructured":"Committee on Classification of Regional Lymph Nodes of Japan Society of Clinical Oncology (2003) Classification of regional lymph nodes in Japan. Int J Clin Oncol 8:248\u2013275","journal-title":"Int J Clin Oncol"},{"key":"741_CR8","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/00000658-199506000-00017","volume":"221","author":"H.A. Pitt","year":"1995","unstructured":"Pitt HA, Nakeeb A, Abrams RA, et al. (1995) Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg 221:788\u2013798","journal-title":"Ann Surg"},{"key":"741_CR9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.coc.0000139017.90599.f5","volume":"28","author":"D.E. Stein","year":"2005","unstructured":"Stein DE, Heron DE, Rosato EL, et al. (2005) Positive microscopic margins alter outcome in lymph node-negative cholangiocarcinoma when resection is combined with adjuvant radiotherapy. Am J Clin Oncol 28:21\u201323","journal-title":"Am J Clin Oncol"},{"key":"741_CR10","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0360-3016(02)02952-8","volume":"54","author":"S. Kim","year":"2002","unstructured":"Kim S, Kim SW, Bang YJ, et al. (2002) Role of postoperative radio-therapy in the management of extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys 54:414\u2013419","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"741_CR11","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM199408253310803","volume":"331","author":"M.J. O\u2019Connell","year":"1994","unstructured":"O\u2019Connell MJ, Martenson JA, Wieand HS, et al. (1994) Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331:502\u2013507","journal-title":"N Engl J Med"},{"key":"741_CR12","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0360-3016(00)00496-X","volume":"47","author":"H.A. Child","year":"2000","unstructured":"Child HA, Spencer SA, Raben D, et al. (2000) A phase I study of combined UFT plus leucovorin and radiotherapy for pancreatic cancer. Int J Radiat Oncol Biol Phys 47:939\u2013944","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"741_CR13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.radonc.2004.01.004","volume":"70","author":"P. Bystr\u00f6m","year":"2004","unstructured":"Bystr\u00f6m P, Fr\u00f6din JE, Berglund A, et al. (2004) Phase I study of UFT plus leucovorin with radiotherapy in patients with inextirpable non-rectal gastrointestinal cancer. Radiother Oncol 70:171\u2013175","journal-title":"Radiother Oncol"},{"key":"741_CR14","first-page":"783","volume":"48","author":"S. Kubicka","year":"2001","unstructured":"Kubicka S, Rudolph KL, Tietze MK, et al. (2001) Phase 2 study of systemic gemcitabine chemotherapy for advanced unresecrable hepatobiliary carcinomas. Hepatogastroenterology 48:783\u2013789","journal-title":"Hepatogastroenterology"},{"key":"741_CR15","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/sj.bjc.6602208","volume":"91","author":"H. Ueno","year":"2004","unstructured":"Ueno H, Okusaka T, Ikeda M, et al. (2004) Phase 2 study of S-1 in patients with advanced biliary tract cancer. Br J Cancer 91:1769\u20131774","journal-title":"Br J Cancer"},{"key":"741_CR16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1023\/A:1008241008379","volume":"9","author":"M. Ducreux","year":"1998","unstructured":"Ducreux M, Rougier P, Fandi A, et al. (1998) Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin. Ann Oncol 9:653\u2013656","journal-title":"Ann Oncol"},{"key":"741_CR17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/annonc\/mdi046","volume":"16","author":"S. Thongprasert","year":"2005","unstructured":"Thongprasert S, Napapan S, Charoentum C, et al. (2005) Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma. Ann Oncol 16:279\u2013281","journal-title":"Ann Oncol"},{"key":"741_CR18","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/annonc\/mdh351","volume":"15","author":"T. Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 T, Tournigand C, Rosmorduc O, et al. (2004) Gemictabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Ann Oncol 15:1339\u20131343","journal-title":"Ann Oncol"},{"key":"741_CR19","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1200\/JCO.2005.51.008","volume":"23","author":"J.J. Knox","year":"2005","unstructured":"Knox JJ, Hedley D, Oza D, et al. (2005) Combination gemcitabine and capecitabine in patients with advanced biliary cancer: a phase 2 trial. J Clin Oncol 23:2332\u20132338","journal-title":"J Clin Oncol"},{"key":"741_CR20","first-page":"1355","volume":"9","author":"K. Hayashi","year":"2002","unstructured":"Hayashi K, Imaizumi T, Uchida K, et al. (2002) High response rates in patients with pancreatic cancer using the novel oral fluoropyrimidine S-1. Oncol Rep 9:1355\u20131361","journal-title":"Oncol Rep"},{"key":"741_CR21","first-page":"165a","volume":"20","author":"A. Ohtsu","year":"2001","unstructured":"Ohtsu A, Boku N, Nagashima F, et al. (2001) A phase I\/II study of S-1 plus cisplatin (CDDP) in patients (pts) with advanced gastric cancer (AGC). Proceedings of ASCO Annual Meeting 20:165a","journal-title":"Proceedings of ASCO Annual Meeting"},{"key":"741_CR22","first-page":"1944","volume":"33","author":"T. Masuda","year":"2006","unstructured":"Masuda T, Beppu T, Ishiko T, et al. (2006) A long-term survival case of advanced intrahepatic cholangiocarcinoma treated with multidisciplinary treatment. Jpn J Cancer Chemother 33:1944\u20131946","journal-title":"Jpn J Cancer Chemother"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-007-0741-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-007-0741-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-007-0741-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:24:47Z","timestamp":1559147087000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-007-0741-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["741"],"URL":"https:\/\/doi.org\/10.1007\/s10147-007-0741-3","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}